Physician sample valuation under excise rules: comparable trade packs, cost-based valuation, limitation, and penalty turned on bona fide dispute.

Physician samples had to be valued under the applicable valuation regime for the relevant period, using the prescribed method for that period. For the pre-2000 period, valuation on a comparable trade-pack basis was upheld, while cost construction was not accepted; the substantive demand for that period survived. For the post-2000 period, valuation at 115% of cost of production in line with the departmental circular was accepted and the contrary computation was rejected. The demand for the earlier period was not time-barred because the valuation method and price lists had been disclosed, and penalty was unwarranted where the dispute was a bona fide valuation controversy. The prior unappealed remand direction also attained finality.

---

---

Issues: (i) Whether the demand relating to physician samples was barred by limitation in view of the disclosed valuation method and the filed price lists; (ii) whether physician samples were to be valued under the 2000 Valuation Rules in accordance with the departmental circular at 115% of cost of production; (iii) whether the Revenue could, by appealing against the Assistant Commissioner's order, indirectly challenge an earlier unappealed remand direction of the Commissioner (Appeals); (iv) whether the valuation of physician samples under the 1975 Valuation Rules was to be made on the basis of comparable trade packs or cost construction, and whether penalty was warranted in valuation disputes.

Issue (i): Whether the demand relating to physician samples was barred by limitation in view of the disclosed valuation method and the filed price lists.

Analysis: The appellants had regularly filed price lists for both trade packs and physician samples and had disclosed the cost construction method adopted for valuation. On those facts, suppression of material particulars could not be sustained. The demand was raised beyond the permissible period and the department had notice of the valuation method being followed.

Conclusion: The demand was held to be time-barred and the issue was decided in favour of the assessee.

Issue (ii): Whether physician samples were to be valued under the 2000 Valuation Rules in accordance with the departmental circular at 115% of cost of production.

Analysis: For the post-2000 period, physician samples were not sold and therefore section 4(1)(a) was inapplicable. The Board's circular clarified that the residuary valuation provision, read with the cost-based rule, required adoption of 115% of the cost of production. The valuation method adopted by the appellants was consistent with that clarification, and a contrary computation had no force.

Conclusion: The Commissioner's contrary valuation was set aside and the issue was decided in favour of the assessee.

Issue (iii): Whether the Revenue could, by appealing against the Assistant Commissioner's order, indirectly challenge an earlier unappealed remand direction of the Commissioner (Appeals).

Analysis: The earlier appellate remand had directed valuation under Rule 6(b)(ii), and that order had not been appealed by the Revenue. The Assistant Commissioner merely acted in compliance with that binding direction. An appeal against the consequential order could not be used to bypass the finality of the earlier remand order or to make the appellate authority sit in appeal over its own earlier direction.

Conclusion: The impugned order was set aside on the ground of appellate finality, in favour of the assessee.

Issue (iv): Whether the valuation of physician samples under the 1975 Valuation Rules was to be made on the basis of comparable trade packs or cost construction, and whether penalty was warranted in valuation disputes.

Analysis: For the earlier period, physician samples were excisable goods and their value could not be treated as nil merely because they were distributed free. Where comparable trade packs were available, valuation on a pro rata/comparable basis was appropriate rather than cost construction. The earlier Tribunal reasoning on the same assessee's physician samples was followed. However, the issue was essentially one of valuation and involved competing legal views, so the imposition of penalty under the penal rule was not justified.

Conclusion: The valuation demand was sustained on merits for the relevant earlier period, but the penalties were set aside.

Final Conclusion: The appeals were disposed of with relief on limitation, post-2000 valuation, appellate finality, and penalty, while the substantive valuation demand for the earlier period was upheld.

Ratio Decidendi: Physician samples, being excisable goods cleared free of charge, must be valued under the applicable valuation rules by reference to the legally prescribed method for the relevant period, but penalty is not warranted where the dispute turns on a bona fide and debatable question of valuation and a prior unchallenged appellate direction has attained finality.

---